AdvanSix (ASIX) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
20 Feb, 2026Executive summary
Delivered full-year adjusted EBITDA of $157 million in 2025, with strong Plant Nutrients performance offsetting nylon troughs and higher input costs; generated $6 million of free cash flow and completed planned plant turnarounds at the lower end of cost expectations.
Achieved record annual production in ammonia and sulfuric acid units, supported by ongoing debottlenecking and maintenance investments.
Received $26 million settlement proceeds related to a 2019 supplier shutdown and preserved a competitive dividend with conservative debt leverage and ample liquidity.
End market environment entering 2026 remains mixed, with continued strength in Plant Nutrients and ongoing challenges in Nylon Solutions.
Financial highlights
Q4 2025 sales reached $360 million, up 9% year-over-year, with sales volume up 11% due to prior year turnaround impacts.
Adjusted EBITDA for Q4 was $25 million (6.9% margin), up $15 million year-over-year, driven by higher volumes and lower turnaround costs.
Full-year 2025 sales were $1.5 billion, nearly flat year-over-year; Adjusted EBITDA margin expanded to 10.3%.
FY25 net income was $44 million; free cash flow increased $5 million year-over-year to $6 million.
Capital expenditures for 2025 were $133.7 million, up from $116.4 million in 2024.
Outlook and guidance
2026 CapEx expected at $75–$95 million, reflecting risk-based prioritization and continued growth investments.
Expect continued robust demand and pricing for Plant Nutrients, with sulfur nutrition demand growing 3%-4%.
Raw material input costs, especially sulfur and natural gas, will be a headwind in early 2026; anticipate $8-$10 million Q1 earnings impact from winter storm disruptions, to be offset later in the year.
Plant turnaround pre-tax income impact expected at $20-$25 million, mostly in Q2 2026.
Multi-year productivity and cost savings program targeting $30 million annual run rate savings.
Latest events from AdvanSix
- Q2 2024 sales and earnings rose on strong nylon, ammonium sulfate, and acetone demand.ASIX
Q2 20242 Feb 2026 - Diversified growth, strong sulfur nutrition demand, and disciplined capital strategy drive outlook.ASIX
CL King’s 22nd Annual Best Ideas Conference 202420 Jan 2026 - Q3 sales up 23% to $398M; $12M USDA grant and Hopewell maintenance impact highlighted.ASIX
Q3 202417 Jan 2026 - FY24 net income was $44.1M on $1.52B sales; cash flow and 2025 outlook remain strong.ASIX
Q4 202423 Dec 2025 - Proxy covers director elections, auditor ratification, pay, ESG, and governance reforms.ASIX
Proxy Filing1 Dec 2025 - Proxy covers director elections, auditor, compensation, stock plan, and officer liability amendment.ASIX
Proxy Filing1 Dec 2025 - Board recommends all proxy proposals, including director elections and charter amendment.ASIX
Proxy Filing1 Dec 2025 - Updated voting rules clarify effects of abstentions and non-votes on all annual meeting proposals.ASIX
Proxy Filing1 Dec 2025 - Q1 2025 saw strong sales, profit rebound, and Plant Nutrients growth, aided by insurance proceeds.ASIX
Q1 202528 Nov 2025